News and Press Releases
Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting
4 April 2025 -- Valby, Denmark -- H. Lundbeck A/S (Lundbeck) to present positive interim results from the PACIFIC trial open-label extension investigating bexicaserin, in addition to new analyses from...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 4, 2025
WCG Announces Research Resilience Solutions to Navigate Institutional Budget Constraints
3 April 2025 -- North Carolina, US -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the release of Research Resilience Solutions, a...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 3, 2025
PEPITEM sequence shows effects in psoriasis, comparable to steroid cream
3 April 2025 -- Birmingham, UK -- Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: April 3, 2025
Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines
Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and China for potential use in immune thrombocytopenia. 3 April...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 3, 2025
Astellas and Japanese Foundation for Cancer Research Announce Collaboration to Accelerate Translational and Clinical Oncology Research
Initial collaboration will support projects of mutual interest and help accelerate advancement of Astellas’ early-stage oncology pipeline 2 April 2025 -- Tokyo, Japan -- Astellas Pharma Inc and Japanese Foundation...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 2, 2025
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial
2 April 2025 -- New York, US -- Tiziana Life Sciences, Ltd, a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: April 2, 2025
Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein (a-syn) antibody levels on average over 20-fold higher than placebo after 4 immunizations Repeated immunizations amplify the anti-a-syn antibody response, supporting boostability and...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: April 2, 2025
Bend Bioscience Adds Commercial Spray Drying & Granulation in Georgia
2 April 2025 – Clearwater, Florida, US – Bend Bioscience, a leading innovation, science, and pharmaceutical services partner, today announced the addition of a commercial-scale spray dryer and a Gerteis...
Category: Drug Delivery
Posted: April 2, 2025
SHL Medical opens new US$220 million manufacturing facility in the US to serve growing autoinjector market
1 April 2025 – SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-of-the-art manufacturing facility in North Charleston,...
Category: Drug Delivery, Manufacturing and Packing
Posted: April 2, 2025
NICE publishes guidance in England & Wales recommending Altuvoct (efanesoctocog alfa) as a treatment option for people with severe haemophilia A aged 2 years and over
2 April 2025 -- Stockholm, Sweden -- Sobi in the UK today announced that the National Institute for Health and Care Excellence (NICE) has issued its Final Guidance in England...
Category: Clinical Trials, Other, Pharmaceutical
Posted: April 2, 2025
CSL Behring and GKV-Spitzenverband Agree on Reimbursement Price for HEMGENIX® – Europe’s First Gene Therapy for Haemophilia B
2 April 2025 -- Marburg, Germany -- CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have successfully concluded negotiations on the reimbursement price of HEMGENIX. This...
Category: Other, Pharmaceutical
Posted: April 2, 2025
Phesi launches self-service Investigator Site Profiler solution to enhance precision of investigator site selection
Solution benefits clinical development and medical affairs groups – eliminating 20%-30% of investigator sites where there isn’t sufficient data to ensure performance 2 April 2025 -- Massachusetts, US -- Phesi,...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 2, 2025
Myonex Unveils Enhanced Services for a Simplified Experience
31 March 2025 – Horsham, PA, US – Myonex, a global leader in clinical trial supply and pharmaceutical commercial services, has announced new and expanded, integrated offerings to better address...
Category: Clinical Trials, Logistics, Pharmaceutical
Posted: April 1, 2025
Besins Healthcare UK launches Prometrium (progesterone) 400mg soft vaginal capsules
The first and only licensed treatment in the UK for the prevention of miscarriage in women with early pregnancy bleeding and a history of recurrent miscarriage 1 April 2025 --...
Category: Other, Pharmaceutical
Posted: April 1, 2025
Besins Healthcare Monaco S.A.M., Le Concorde, 11 rue du Gabian - 98000 MONACO
Navigo Proteins Announces Strategic R&D Collaboration with SCK CEN to Develop Targeted Radiotheranostics
1 April 2025 -- Halle, Germany and Mol, Belgium -- Navigo Proteins GmbH, a leader in precision medicine and next-generation radiotheranostics, today announced a strategic research collaboration with SCK CEN,...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: April 1, 2025
